End of life care in advanced heart failure

Current Treatment Options in Cardiovascular Medicine

Volumn 13, Issue 1, 2011, Pages 79-89

  Lewis, Eldrin F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; NITRATE; OPIATE;

ANXIETY; ANXIETY DISORDER; ARTICLE; CALORIC INTAKE; CARDIAC RESYNCHRONIZATION THERAPY; DEPRESSION; DISEASE COURSE; DIZZINESS; DOCTOR PATIENT RELATION; DRUG INDUCED HEADACHE; DYSPNEA; EXERCISE; FATIGUE; FUNCTIONAL STATUS; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE PLANNING; HEART FAILURE; HEART TRANSPLANTATION; HOSPICE CARE; HUMAN; HYPOTENSION; LIVING WILL; MEDICAL DECISION MAKING; OPTIMISM; OUTCOME ASSESSMENT; PAIN; PALLIATIVE THERAPY; PATIENT PREFERENCE; PATIENT SATISFACTION; PROGNOSIS; QUALITY OF LIFE; SOCIAL SUPPORT; SURVIVAL; TAI CHI; VIRTUAL REALITY;

EID: 79551612897     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-010-0100-y     Document Type: Article

References (49)

1. D Lloyd-Jones RJ Adams TM Brown, et al. 2010 Heart disease and stroke statistics-2010 update: a report from the American Heart Association Circulation 121 e46 e215 10.1161/CIRCULATIONAHA.109.192667 20019324
2. EF Lewis GA Lamas E O'Meara, et al. 2007 Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM Eur J Heart Fail 9 83 91 10.1016/j.ejheart.2006. 10.012 17188020 This article demonstrates that quality of life is similarly impaired in low and preserved EF heart failure patients, and thus new strategies should be found for all patients (Pubitemid 46074490)
3. SA Hunt WT Abraham MH Chin, et al. 2005 ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation. Endorsed by the Heart Rhythm Society Circulation 112 e154 235 10.1161/CIRCULATIONAHA.105.167586 16160202
4. VL Roger SA Weston MM Redfield, et al. 2004 Trends in heart failure incidence and survival in a community-based population JAMA 292 344 350 1:CAS:528:DC%2BD2cXlvFaju7k%3D 10.1001/jama.292.3.344 15265849 (Pubitemid 38944258)
5. MR Costanzo RM Mills J Wynne 2008 Characteristics of "Stage D" heart failure: insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM) Am Heart J 155 339 347 10.1016/j.ahj.2007.10.020 18215606
6. M Kittleson S Hurwitz MR Shah, et al. 2003 Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality J Am Coll Cardiol 41 2029 2035 1:CAS:528:DC%2BD3sXltFGjs7k%3D 10.1016/S0735-1097(03)00417- 0 12798577 (Pubitemid 36677127)
7. M Jessup WT Abraham DE Casey, et al. 2009 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 1977 2016 10.1161/CIRCULATIONAHA.109.192064 19324967
8. J Lindenfeld NM Albert JP Boehmer, et al. 2010 HFSA 2010 Comprehensive Heart Failure Practice Guideline J Card Fail 16 e1 194 10.1016/j.cardfail.2010. 04.004 20610207
9. TA Balboni ME Paulk MJ Balboni, et al. 2010 Provision of spiritual care to patients with advanced cancer: associations with medical care and quality of life near death J Clin Oncol 28 445 452 10.1200/JCO.2009.24.8005 20008625
10. HA Tindle YF Chang LH Kuller, et al. 2009 Optimism, cynical hostility, and incident coronary heart disease and mortality in the Women's Health Initiative Circulation 120 656 662 10.1161/CIRCULATIONAHA.108.827642 19667234
11. EJ Giltay JM Geleijnse FG Zitman, et al. 2004 Dispositional optimism and all-cause and cardiovascular mortality in a prospective cohort of elderly Dutch men and women Arch Gen Psychiatry 61 1126 1135 10.1001/archpsyc.61.11.1126 15520360 (Pubitemid 39463414)
12. PJ Allison C Guichard K Fung L Gilain 2003 Dispositional optimism predicts survival status 1 year after diagnosis in head and neck cancer patients J Clin Oncol 21 543 548 10.1200/JCO.2003.10.092 12560447 (Pubitemid 46613491)
13. KD Aaronson JS Schwartz TM Chen, et al. 1997 Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation Circulation 95 2660 2667 1:STN:280:DyaK2szjs1Krug%3D%3D 9193435
14. HU Stempfle A Alt J Stief U Siebert 2008 The Munich score: a clinical index to predict survival in ambulatory patients with chronic heart failure in the era of new medical therapies J Heart Lung Transplant 27 222 228 10.1016/j.healun.2007.10.016 18267231 (Pubitemid 351222640)
15. WC Levy D Mozaffarian DT Linker, et al. 2006 The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 1424 1433 10.1161/CIRCULATIONAHA.105.584102 16534009 (Pubitemid 43739439)
16. GC Fonarow KF Adams Jr WT Abraham, et al. 2005 Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis JAMA 293 572 580 1:CAS:528:DC%2BD2MXhtVWqsLg%3D 10.1001/jama.293.5.572 15687312 (Pubitemid 40171239)
17. DS Lee PC Austin JL Rouleau, et al. 2003 Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model JAMA 290 2581 2587 1:CAS:528:DC%2BD3sXpt1Cmu7s%3D 10.1001/jama.290.19. 2581 14625335 (Pubitemid 37443288)
18. NA Christakis EB Lamont 2000 Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study BMJ 320 469 472 1:STN:280:DC%2BD3c7ktlKisQ%3D%3D 10.1136/bmj.320.7233.469 10678857
19. JA Spertus 2008 Evolving applications for patient-centered health status measures Circulation 118 2103 2110 10.1161/CIRCULATIONAHA.107.747568 19001034
20. P Vaishnava EF Lewis 2007 Assessment of quality of life in severe heart failure Curr Heart Fail Rep 4 170 177 10.1007/s11897-007-0037-y 17883994 (Pubitemid 47493064)
21. EF Lewis PA Johnson W Johnson, et al. 2001 Preferences for quality of life or survival expressed by patients with heart failure J Heart Lung Transplant 20 1016 1024 1:STN:280:DC%2BD3MrhtVWntQ%3D%3D 10.1016/S1053-2498(01) 00298-4 11557198 (Pubitemid 32824149)
22. LW Stevenson AS Hellkamp CV Leier, et al. 2008 Changing preferences for survival after hospitalization with advanced heart failure J Am Coll Cardiol 52 1702 1708 10.1016/j.jacc.2008.08.028 19007689
23. MI Hertz P Aurora JD Christie, et al. 2008 Registry of the International Society for Heart and Lung Transplantation: a quarter century of thoracic transplantation J Heart Lung Transplant 27 937 942 10.1016/j.healun.2008.07.019 18765185
24. MS Slaughter JG Rogers CA Milano, et al. 2009 Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2241 2251 1:CAS:528:DC%2BD1MXhsFWgs7%2FE 10.1056/NEJMoa0909938 19920051 Continuous-flow LVADs are associated with better cardiovascular outcomes, improved quality of life, and more durability compared with pulsatile pumps making, this a more appealing therapy for Stage D patients
25. JK Kirklin DC Naftel RL Kormos, et al. 2010 Second INTERMACS annual report: more than 1, 000 primary left ventricular assist device implants J Heart Lung Transplant 29 1 10 10.1016/j.healun.2009.10.009 20123242
26. SR Wilson GH Mudge Jr GC Stewart MM Givertz 2009 Evaluation for a ventricular assist device: selecting the appropriate candidate Circulation 119 2225 2232 10.1161/CIRCULATIONAHA.109.850610 19398678
27. AF Hernandez AM Shea CA Milano, et al. 2008 Long-term outcomes and costs of ventricular assist devices among Medicare beneficiaries JAMA 300 2398 2406 1:CAS:528:DC%2BD1cXhsVCjsr7K 10.1001/jama.2008.716 19033590
28. M Metra E Eichhorn WT Abraham, et al. 2009 Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials Eur Heart J 30 3015 3026 1:CAS:528:DC%2BD1MXhsFyrsrzM 10.1093/eurheartj/ehp338 19700774
29. CW Yancy H Krum BM Massie, et al. 2008 Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial Circ Heart Fail 1 9 16 1:CAS:528:DC%2BD1cXosFGnsLk%3D 10.1161/CIRCHEARTFAILURE.108.767483 19808265 Intermittent outpatient infusion of nesiritide is not associated with better outcomes; however, intensive follow-up improved outcomes beyond expected historical controls
30. RC Bourge WT Abraham PB Adamson, et al. 2008 Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study J Am Coll Cardiol 51 1073 1079 10.1016/j.jacc.2007.10.061 18342224 Hemodynamic monitoring requires further testing to determine its role in advanced heart failure patients (Pubitemid 351374766)
31. ED Adler JZ Goldfinger J Kalman, et al. 2009 Palliative care in the treatment of advanced heart failure Circulation 120 2597 2606 10.1161/CIRCULATIONAHA.109.869123 20026792
32. S Setoguchi RJ Glynn M Stedman, et al. 2010 Hospice, opiates, and acute care service use among the elderly before death from heart failure or cancer Am Heart J 160 139 144 10.1016/j.ahj.2010.03.038 20598984 This articles shows that hospice use is underutilized in heart failure patients
33. SJ Goodlin 2009 Palliative care in congestive heart failure J Am Coll Cardiol 54 386 396 10.1016/j.jacc.2009.02.078 19628112
34. K Dracup 2002 Beyond the patient: caring for families Commun Nurs Res 35 53 61 12430200
35. DB Mark KJ Anstrom JL Sun, et al. 2008 Quality of life with defibrillator therapy or amiodarone in heart failure N Engl J Med 359 999 1008 1:CAS:528:DC%2BD1cXhtVymurnO 10.1056/NEJMoa0706719 18768943
36. Padeletti L, Arnar DO, Boncinelli L, et al.: EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace 2010, 12(10):1480-1489.
37. S Sherazi JP Daubert RC Block, et al. 2008 Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator Mayo Clin Proc 83 1139 1141 10.4065/83.10.1139 18828973
38. AM Walling SM Asch KA Lorenz, et al. 2010 The quality of care provided to hospitalized patients at the end of life Arch Intern Med 170 1057 1063 10.1001/archinternmed.2010.175 20585072
39. Publication Committee for the VMAC Investigators: Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 2002, 287:1531-1540.
40. TP Chua D Harrington P Ponikowski, et al. 1997 Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure J Am Coll Cardiol 29 147 152 1:CAS:528:DyaK2sXntVyltQ%3D%3D 10.1016/S0735-1097(96)00446-9 8996307 (Pubitemid 27028732)
41. M Hochgerner FM Fruhwald I Strohscheer 2009 Opioids for symptomatic therapy of dyspnoea in patients with advanced chronic heart failure-is there evidence? Wien Med Wochenschr 159 577 582 10.1007/s10354-009-0726-0 20151346
42. S Redline EF Lewis 2010 Gravitational influences and shifting propensity for sleep apnea: another source of heterogeneity or a new intervention target? Circulation 121 1583 1585 10.1161/CIR.0b013e3181dd3e5f 20351240
43. GY Yeh MJ Wood BH Lorell, et al. 2004 Effects of tai chi mind-body movement therapy on functional status and exercise capacity in patients with chronic heart failure: a randomized controlled trial Am J Med 117 541 548 10.1016/j.amjmed.2004.04.016 15465501 (Pubitemid 39304203)
44. MD Sullivan K Newton J Hecht, et al. 2004 Depression and health status in elderly patients with heart failure: a 6-month prospective study in primary care Am J Geriatr Cardiol 13 252 260 10.1111/j.1076-7460.2004.03072.x 15365288
45. CM O'Connor W Jiang M Kuchibhatla, et al. 2010 Safety and efficacy of sertraline for depression in patients with heart failure. Results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) Trial J Am Coll Cardiol 56 692 699 10.1016/j.jacc.2010.03.068 20723799 The use of sertraline for treatment of depression in heart failure patients did not improve health status. This class of medicine may aggravate hyponatremia
46. MJ Sullivan L Wood J Terry, et al. 2009 The Support, Education, and Research in Chronic Heart Failure Study (SEARCH): a mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failure Am Heart J 157 84 90 10.1016/j.ahj.2008.08. 033 19081401
47. M Mamdani DN Juurlink DS Lee, et al. 2004 Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study Lancet 363 1751 1756 1:CAS:528:DC%2BD2cXksVanu7o%3D 10.1016/S0140-6736(04)16299-5 15172772 (Pubitemid 38698377)
48. MA Konstam M Gheorghiade JC Burnett Jr, et al. 2007 Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial JAMA 297 1319 1331 1:CAS:528:DC%2BD2sXjs1ejtrg%3D 10.1001/jama.297.12.1319 17384437 (Pubitemid 46513233)
49. MJ Silveira SY Kim KM Langa 2010 Advance directives and outcomes of surrogate decision making before death N Engl J Med 362 1211 1218 1:CAS:528:DC%2BC3cXkt1ehu7k%3D 10.1056/NEJMsa0907901 20357283 More communication and establishment of advanced directives may improve outcomes in heart failure patients. Surrogate decisions are often required due to cognitive deficits in the patient